Shi Qing Cheng
Direttore/Membro del Consiglio presso Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Profilo
Shi Qing Cheng is currently the Vice Chairman at Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
Prior to this, he graduated from Peking University with a graduate degree in 1999 and from Renmin University of China with an undergraduate degree in 1982.
Posizioni attive di Shi Qing Cheng
| Società | Posizione | Inizio |
|---|---|---|
Beijing Tri Prime Gene Pharmaceutical Co., Ltd.
 Beijing Tri Prime Gene Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Tri Prime Gene Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biomedicine. Its key products include human interferon a1b for injection, human interferon a1b injection, human interferon a1b eye drops, and recombinant human interferon a1b spray. The company was founded by Yun De Hou and Yong Qing Cheng on September 24, 1992 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 18/11/2021 |
Formazione di Shi Qing Cheng
| Peking University | Graduate Degree |
| Renmin University of China | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
 | Health Technology |
- Borsa valori
- Insiders
- Shi Qing Cheng
